We use cookies to understand how visitors search for and consume the information we provide, so that we can improve their experience. By browsing this website, you indicate your acceptance of the use of such cookies
Accept
Read more
Direct accesses
Go to main menu
Go to main content
Menu
Search the site
Contact
Careers
You are viewing the website in English
en
fr
Search the site
Who
we are
Company
Leadership
Collaborations
Our products
& pipeline
Diseases we target
GS010 for LHON
GS030 for Retinitis Pigmentosa
GS030 for Geographic Atrophy in Dry-AMD
Our
technologies
Technologies we are applying
Gene Therapy
Mitochondrial Targeting Sequence (MTS)
Optogenetics
Investors
& media
Company Overview
Press releases
Events & presentations
News and press coverage
Stock information
Governance
Documentation
Events & presentations
Year
All
2021
2020
2019
2018
2017
2016
2015
2014
2013
News type
All
Regulatory
Clinical
Conferences
Corporate
Finance
General Meeting
Product candidates
Science & Technology
Other
Subject
All
Company and personnel
GS010 - LUMEVOQ
GS030
Technologies
Other
29 Apr 2021
Annual General Meeting 2021
27 Apr 2021 - 29 Apr 2021
Mitochondria-Targeted Drug Development Summit, Digital
17 Apr 2021 - 22 Apr 2021
2021 AAN Annual Meeting, virtual
06 Apr 2021 - 09 Apr 2021
Cell & Gene Meeting on the Mediterranean, virtual
25 Mar 2021
Ophthalmology Future Forums – Asian Retina Virtual Forum
22 Mar 2021 - 25 Mar 2021
BioEurope Spring – virtual
22 Feb 2021 - 25 Feb 2021
4th Annual Gene Therapy for Rare Disorders – virtual
20 Feb 2021 - 23 Feb 2021
47th NANOS Annual Meeting – Virtual Meeting
18 Feb 2021
OIS Gene Therapy Innovation Showcase – virtual
06 Feb 2021 - 07 Feb 2021
44th Annual Macula Society Meeting – Virtual
View previous 9 articles
1
2
3
4
5
6
7
…
15
View next 9 articles
Go back to the page of the page
